Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?
Dechend, R.; Derer, W.; Müller, D.N.
MMW Fortschritte der Medizin 151(45): 46-47
2009
ISSN/ISBN: 1438-3276 PMID: 19960726 Document Number: 628523
Document emailed within 1 workday
Related Documents
Fomin, V.V. 2012: Fixed dose combinations of antihypertensive drugs and management of risk of development nephropathy in type 2 diabetes mellitus Kardiologiia 52(10): 81-85Laganović, M. 2010: Fixed combinations of antihypertensive medications--new opportunity in treatment of hypertension Lijecnicki Vjesnik 132(3-4): 94-98
Umemura, S. 2011: Advantage and disadvantages of single-pill (fixed) antihypertensive drug combinations Nihon Rinsho. Japanese Journal of Clinical Medicine 69(11): 2042-2048
Skoularigis, J.; Strugo, V.; Radevski, I.; Hlatswayo, Z.; Sareli, P. 1997: Once-daily fixed dose combinations of verapamil and trandolapril in black patients with mild to moderate hypertension: a new choice for first line treatment International Journal of Clinical Pharmacology and Therapeutics 35(2): 51-55
Aicher, B.; Kraupp, O. 1996: Effectiveness of fixed analgesic combinations exemplified by thomapyrin Wiener Klinische Wochenschrift 108(8): 219-233
Hemanth Kumar, A.K.; Ramachandran, G.; Rajasekaran, S.; Padmapriyadarsini, C.; Narendran, G.; Anitha, S.; Subramanyam, S.; Kumaraswami, V.; Swaminathan, S. 2009: Pharmacokinetics of lamivudine and stavudine in generic fixed-dose combinations in HIV-1 infected adults in India Indian Journal of Medical Research 130(4): 451-457
Desakorn, V.; Karmacharya, B.Man.; Thanachartwet, V.; Kyaw, N.Lin.; Tansuphaswadikul, S.; Sahassananda, D.; Dhitavat, J.; Maek-a-nantawat, W.; Pitisuttithum, P. 2011: Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: a 3-year follow-up Southeast Asian Journal of Tropical Medicine and Public Health 42(6): 1414-1422
Kobalava, Z.D.; Kotovskaia, I.V.; Lobzhanidze, T.V.; Kravtsova, O.A. 2014: Optimization of arterial hypertension management by the use of two- and three-drugs fixed dose combinations at the daily stay department Kardiologiia 54(7): 17-24
Krudsood, S.; Tangpukdee, N.; Thanchatwet, V.; Wilairatana, P.; Srivilairit, S.; Pothipak, N.; Jianping, S.; Guoqiao, L.; Brittenham, G.M.; Looareesuwan, S. 2007: Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria Southeast Asian Journal of Tropical Medicine and Public Health 38(6): 971-978
Muiño Miguez, A.; López Glez-Cobos, C.; Villalba García, M.V.; Segado Soriano, A.; Granda Martín, M.J.; Gil Gómez, J. 1999: Fixed-dosage combinations in the treatment of hypertension Anales de Medicina Interna 16(2): 92-96
Pujari, S.; Dravid, A.; Gupte, N.; Joshi, K.; Bele, V. 2008: Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India Medscape Journal of Medicine 10(8): 196
Lung, T.; Jan, S.; de Silva, H.A.; Guggilla, R.; Maulik, P.K.; Naik, N.; Patel, A.; de Silva, A.P.; Rajapakse, S.; Ranasinghe, G.; Prabhakaran, D.; Rodgers, A.; Salam, A.; Selak, V.; Stepien, S.; Thom, S.; Webster, R.; Lea-Laba, T. 2019: Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial LANCET. Global Health 7(10): E1359-E1366
Mallion, J.M.; Benkritly, A.; Hansson, L.; Zanchetti, A. 1999: Effect of intensive antihypertensive treatment and of aspirin in a low dose in the hypertensive. the HOT (Hypertension Optimal Treatment) study Archives des Maladies du Coeur et des Vaisseaux 92(8): 1073-1078
Zorić, M.; Jarebica, M.; Teofanović, D.; Toula, Z.; Milicević, N. 1977: Evaluation of the effectiveness of different combinations of antituberculosis drugs in the treatment of pulmonary TB (author's transl Plucne Bolesti i Tuberkuloza 29(3-4): 207-217
Lehmann, H.U.; Meyer-Estorf, G.; Hochrein, H. 1978: Clinical effectiveness of BQ 22-708, a pyridopyridazine derivative, in the treatment of fixed essential hypertension Die Medizinische Welt 29(24): 1007-1012
Rustenbeck, I. 2009: Fixed drug combinations--the pros and the cons Medizinische Monatsschrift für Pharmazeuten 32(4): 141-146
Soll, D.B.; Weston, J.M. 1979: Ophthalmic fixed-ratio drug combinations American Family Physician 19(4): 156-158
Vaïsse, B.; Silhol, F.; Bouchlagen, K.; Gallois, H.; Poggi, L. 1999: New requirements in the primary treatment of arterial hypertension: why do we need fixed low-dose combination therapy? Presse Medicale 28(9): 500-506
Krcméry, V. 1990: Dual cephalosporins--a return of fixed combinations of antibiotics? Casopis Lekaru Ceskych 129(29): 914-916
Miller, R.Scott.; Wongsrichanalai, C.; Buathong, N.; McDaniel, P.; Walsh, D.S.; Knirsch, C.; Ohrt, C. 2006: Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study American Journal of Tropical Medicine and Hygiene 74(3): 401-406